VOR BIOPHARMA INC

Vor Biopharma slides to $18.22 as investors weigh its weak valuation, limited liquidity, and lack of clinical milestones in a volatile biopharma market.

Vor Biopharma (VOR) slides 0.47 % today to $18.94, down 13.9 % from last month amid mixed biotech moves—learn why the $1.1 B cell‑therapy firm matters.

Vor Biopharma (VOR) rises 5.49% as investors eye its precision cancer cell‑therapy pipeline and 200‑day trend, amid a volatile market and strong peer gains.